Banner

July 24, 2008

Pharmica, Merck, Genzyme Strategies

Finding The Right Metrics

What to count (or not), and why.

PharmaNet Outlook Down

S&P On CRO Industry

PharmaNet was downgraded from stable to negative by Standard and Poor’s, thanks to $60 million in lost contracts. 

Liver Net

CTI: Focussing On Hepatitis

A Cincinnati-based CRO plans to stay medium-sized and private, despite a tidal wave of work that has started to come its way. 

Rocket Man

On NASA, BBC and GSK

The industry’s image takes another hit in Britain. Unsolicited advice on avoiding similar encounters.

Sites, IRBs, CROs Lining Up

Seeking The AAHRPP Seal

AAHRPP, which accredits those in the clinical research industry, has standards that go beyond FDA regs.

Email tool

Consilient Add-on To Palm

March 14, 2006

A tiny Canadian firm, Consilient, hopes to provide cheaper email to handheld computers like Palms and cell phones. Consilient is a partner with RIM, the company responsible for the Blackberry devices, and says its latest product, Consilient Push, can drive down the monthly cost of wireless email to $3 to… more...

Speaking of Safety

Pharsight’s Gao

March 14, 2006

Pharsight’s Senior Scientist Yuying Gao, M.D., Ph.D., will speak to members of the Japanese pharmaceutical industry attending the 28th mini-symposium of the Department of Molecular Pharmacokinetics, to be held at the University of Tokyo on March 23, 2006. Dr. Gao will give a presentation on the strategic value of quantitative… more...

A Model Company

Ingenuity-Aventis Deal

March 14, 2006

Ingenuity Systems today announced that it had expanded the terms of its agreement with Sanofi-Aventis in the U.S. Ingenuity Pathways Analysis (IPA) is a web-delivered software application that enables researchers to model, analyze and understand the complex biological systems at the core of life science research. IPA is deployed in… more...

Irish test

IBM & RFID

March 14, 2006

IBM hopes to participate in the RFID market in a bigger way than previously. To test the radio tracking chips, the computer company has opened a 50,000 square foot test center in Dublin, Ireland. IBM hopes to tune its servers and WebSphere software to handle the rapid monitoring necessary at… more...

Drug safety

Affy, Iconix Partner

February 28, 2006

Affymetrix and Iconix will combine their efforts to provide tools to assess drug toxicity. The collaboration will combine Affymetrix’ GeneChip microarray technology with Iconix’ DrugMatrix 640 compound reference database and analysis software. Affymetrix’ arrays and Iconix’ analysis tools could provide detailed information on a drug candidate’s toxicological liabilities and pharmacological… more...

Maybe Technology Does Work

Health Records, Health Gain

February 28, 2006

Software from TheraDoc (of Utah) and BioMetrieux (of France) is having an impressive effect on patient health. The two companies say their Stellara package, used for clinical intervention and patient monitoring, was used at Franciscan Health Systems in Tacoma, Washington. “We have experienced tremendous success with Stellara as our intelligent… more...

Number Scheme Needed

RFID Report

February 28, 2006

Does the world need more than one RFID (radio frequency identification) standard? Some in the industry think that separate schemes for every industry will lead to chaos. Some packages already have multiple bar codes. In the United States, pharmaceutical drugs have a National Drug Code. Tires have their own number.… more...

IMS, a leading market research firm, says U.S. prescription drug sales grew 5.4 percent to $251.8 billion in 2005. That compares to $238.9 billion in sales in 2004. The volume of total U.S. dispensed prescriptions was up significantly over 2004, growing 4.7 percent. “The pharmaceutical market continues to experience solid… more...

PhRMA's New Numbers

2005 R&D Spend

February 22, 2006

PhRMA released undated figures showing $39 billion in research and development spending in 2005. That’s a 5.4 percent increase from $37 billion in 2004. “America’s research-based biopharmaceutical companies once again lead the world in investing in the hunt for new cures and treatments. It is the most research-intensive industry in… more...

Upbeat Forecast

S&P Eyes Pharma

February 20, 2006

Standard & Poors says that the drug industry will have a good year despite public scrutiny of drug prices and generic competition. “Despite near-term uncertainties over pricing and patent expirations, we think pharmaceuticals remains one of the healthiest and widest-margin U.S. industries,” says Herman Saftlas, an S&P analyst. “We see… more...

Page 12 of 13 pages « First  <  10 11 12 13 >